The skin gateway
to the Immune System

What's New ?

June, 06 2013


DBV Technologies proudly welcomes Mrs. Veronique Foutel as Chief Strategic Marketing Officer

DBV Technologies announced today the appointment of Véronique Foutel as Chief Strategic Marketing Officer. In this position and in full partnership with the other members of the DBV leadership team, Véronique will be accountable for developing a sustainable market access strategy and business model for DBV’s products currently under development. More

A revolutionary approach in allergy treatment

11 to 26 million people suffer from food allergy in Europe while at the global level, the estimate is 220 to 500 million people. 3 to 5% of Americans suffer from food allergies and the prevalence of peanut allergy in children has almost quadrupled from 1997 to 2008…

EPIT Method Video

Missing flash plugin. Please download the latest Adobe Flash Player:
Get Adobe Flash Player

Animation explaining how DBV uses the Epicutaenous Immunotherapy, with its VIASKIN patch to desensitize allergic patients

Legal Mention

CNIL number: 1544201 v 0

DBV technologies - siège social
Green Square - Bâtiment D
80/84 rue des Meuniers
92220 Bagneux
France
Phone: +33 (0)1 55 42 78 78
Fax: +33 (0)1 43 26 10 83

SIRET: 441772522 00013
RCS: Nanterre

Executive editor: Pierre-Henri Benhamou

Hosting service: OVH www.ovh.com

Design : l’enchanteur www.lenchanteur.com

Contact